NR1D1 Stimulates Antitumor Immune Responses in Breast Cancer by Activating cGAS-STING Signaling

Potentiating antitumor immunity is a promising therapeutic approach for treating a variety of cancers, including breast cancer. One potential strategy to promote antitumor immunity is targeting DNA damage response. Given that the nuclear receptor NR1D1 (also known as REV-ERBα) inhibits DNA repair in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ka, Na-Lee, Park, Mi Kyung, Kim, Seung-Su, Jeon, Yoon, Hwang, Sewon, Kim, Sun Mi, Lim, Ga Young, Lee, Ho, Lee, Mi-Ock
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Cancer Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538367/
https://www.ncbi.nlm.nih.gov/pubmed/37395684
http://dx.doi.org/10.1158/0008-5472.CAN-23-0329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538367/
https://www.ncbi.nlm.nih.gov/pubmed/37395684
http://dx.doi.org/10.1158/0008-5472.CAN-23-0329

Ejemplares similares